SCHEMBL164038

SCHEMBL164038

C=C(C(=O)O)C(C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
SLC7A5 Q01650 1/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
XBP1 P17861 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TET2 Q6N021 3/20 0.33
TET3 O43151 1/20 0.33
TET1 Q8NFU7 1/20 0.33
GRIK1 P39086 1/20 0.32
GRIK2 Q13002 1/20 0.32
GRM1 Q13255 1/20 0.32
GRM2 Q14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20790181 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL28322668 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL28323732 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL2816691 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL28876765 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL28322815 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL2815802 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL17178420 0.97 TP53 (0.38) TP53SLC7A5LMNAMAPTXBP1
Acrylic Acid SCHEMBL29198708 0.88 LMNA (0.46) TP53SLC7A5LMNAMAPTXBP1
SCHEMBL2915534 0.88 LMNA (0.46) TP53SLC7A5LMNAMAPTXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4067466-B1 WASHING OR CLEANING AGENT HENKEL AG & CO KGAA (DE) 2026-05-20 EP claimed
CN-115449027-B Acrylic ester polymer, medical adhesive composition and medical adhesive 中国乐凯集团有限公司 2026-05-12 CN claimed
EP-3933019-B1 PROCESS FOR MANUFACTURING A WATER-SOLUBLE UNIT DOSE ARTICLE PROCTER & GAMBLE (US) 2026-04-29 EP claimed
US-20260109952-A1 MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD LUNG BIOTECHNOLOGY PBC (US) 2026-04-23 US claimed
EP-4715941-A1 COMPOSITE ELECTROLYTE MEMBRANE, MANUFACTURING METHOD THEREOF, AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG Energy Solution, Ltd. (KR) 2026-03-25 EP claimed
US-12534708-B2 Material and method for producing cell receiving scaffold LUNG BIOTECHNOLOGY PBC (US) 2026-01-27 US claimed
EP-4126978-B1 PROCESS FOR PREPARING AQUEOUS POLYMER DISPERSIONS COVESTRO NETHERLANDS BV (NL) 2025-11-19 EP claimed
EP-3829662-B1 MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD LUNG BIOTECHNOLOGY PBC (US) 2025-08-20 EP claimed
CN-118743774-A Multifunctional medical pH indicating gauze with antibacterial and antioxidant functions and preparation method thereof 武汉大学中南医院 2024-10-08 CN claimed
CN-118496645-B High-toughness polylactic acid/starch-based composite material and preparation method thereof 泰州泽钰新材料科技有限公司 2024-09-27 CN claimed
US-4298703-A Fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-11-03 US claimed
US-4298705-A Rubber-modified fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-11-03 US claimed
US-4278768-A Rubber-modified fire-retardant anhydride copolymers ARCO POLYMERS, INC. (US) 1981-07-14 US claimed
US-4266037-A Fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-05-05 US claimed
US-4266038-A Rubber-modified fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-05-05 US claimed
US-4048130-A COPOLYMERIZATION, UNSATURATED ACIDS LONZA LTD. (CH) 1977-09-13 US claimed
US-4041056-A CARBON PAPER INKS, POLISHES PETROLITE CORPORATION (US) 1977-08-09 US claimed
US-3993493-A FOR CARBON PAPER PETROLITE CORPORATION (US) 1976-11-23 US claimed
US-3933512-A Carbon paper inks containing wax-anhydride compounds PETROLITE CORPORATION (US) 1976-01-20 US claimed
US-3933511-A Polishes containing wax-anhydride compounds PETROLITE CORPORATION (US) 1976-01-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534708-B2 Material and method for producing cell receiving scaffold COL2A1, COL1A1, COL14A1 TP53 412/4885SLC7A5 3039/4885LMNA 494/4885
US-20260109952-A1 MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD COL2A1, COL1A1, COL14A1 TP53 509/4885SLC7A5 4217/4885LMNA 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.